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Dual-Modal Nanoprobes for Imaging of
Mesenchymal Stem Cell Transplant by
MRI and Fluorescence Imaging
Objective: To determine the feasibility of labeling human mesenchymal stem
cells (hMSCs) with bifunctional nanoparticles and assessing their potential as
imaging probes in the monitoring of hMSC transplantation.
Materials and Methods: The T1 and T2 relaxivities of the nanoparticles
(MNP@SiO2[RITC]-PEG) were measured at 1.5T and 3T magnetic resonance
scanner. Using hMSCs and the nanoparticles, labeling efficiency, toxicity, and
proliferation were assessed. Confocal laser scanning microscopy and transmis-
sion electron microscopy were used to specify the intracellular localization of the
endocytosed iron nanoparticles. We also observed in vitro and in vivo visualiza-
tion of the labeled hMSCs with a 3T MR scanner and optical imaging.
Results: MNP@SiO2(RITC)-PEG showed both superparamagnetic and fluo-
rescent properties. The r1 and r2 relaxivity values of the MNP@SiO2(RITC)-PEG
were 0.33 and 398 mM
-1 s
-1 at 1.5T, respectively, and 0.29 and 453 mM
-1 s
-1 at
3T, respectively. The effective internalization of MNP@SiO2(RITC)-PEG into
hMSCs was observed by confocal laser scanning fluorescence microscopy. The
transmission electron microscopy images showed that MNP@SiO2(RITC)-PEG
was internalized into the cells and mainly resided in the cytoplasm. The viability
and proliferation of MNP@SiO2(RITC)-PEG-labeled hMSCs were not significantly
different from the control cells. MNP@SiO2(RITC)-PEG-labeled hMSCs were
observed in vitro and in vivo with optical and MR imaging.
Conclusion: MNP@SiO2(RITC)-PEG can be a useful contrast agent for stem
cell imaging, which is suitable for a bimodal detection by MRI and optical imaging.
ecent studies suggest that mesenchymal stem cells (MSCs) show signifi-
cant potential as a novel cellular therapy for tissue regeneration (1). The
development of new stem cell-based therapies requires a quantitative and
qualitative assessment of stem cell distribution to the target organs, differentiation
outcome, and engraftment (2, 3). In particular, the monitoring of cell trafficking in
vivo and distinguishing whether cellular regeneration originated from an exogenous
cell source is a key issue for developing successful stem cell therapies (4, 5). Although
magnetic resonance imaging (MRI), radionuclide imaging, and optical imaging are all
used to track the transplanted cells, MRI is progressing towards playing an important
role in the development of stem cell therapy because its ability to demonstrate
anatomic details with high contrast and exquisite spatial resolution, and can noninva-
sively follow stem cells for long periods of time (6, 7).
The detection of the transplanted cells by MRI requires cells to be labeled magneti-
cally either by endocytic internalizing or cell surface attachment of magnetic nanopar-
ticles (MNPs) (8-11). Recently, a variety of magnetic nanoparticles such as superpara-
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Rmagnetic iron oxide (SPIO) have been developed.
Although native iron oxide particles are used as the
currently preferred cell-labeling materials, they have low
intracellular labeling efficiency and the exposed metal ion
on the surface of nanoparticles can cause metal elemental
toxicities in cells (12-14). The surface coating of magnetic
nanoparticles with polystyrene, dextran, and dendrimers
have been reported to improve the cellular-internalization
of contrast agent, but the efficiency of internalization is still
generally low and it requires long-term incubation time
and high concentration of particles (13-15). It is therefore
highly desirable to develop a nanoparticle that is nontoxic,
biocompatible, efficient at intracellular labeling, and highly
sensitive to detection. The current challenges also include
the development of multimodality imaging for compensat-
ing the limited MRI sensitivity and extending its applica-
tion by combining the strengths of different imaging
modalities.
Bifunctional contrast agents with both optical and
magnetic contrast were made using various methods and
demonstrated to serve as good molecular imaging probes
for multimodality imaging (16-18). By incorporating
organic fluorescent dye molecules into the silica-coated
magnetite core-shell, we synthesized uniform dual-
functionalized nanoparticles which permit dual-modality
detections (19, 20). Recently, several noninvasive, MR-
based monitoring methods were used to tract MSCs
transplant. However, the bifunctional magnetofluorescent
nanoparticles as a single molecule have rarely been applied
in MSCs tracking prior to this study. We investigated the
feasibility of labeling human mesenchymal stem cells
(hMSCs) with bifunctional nanoparticles and assessed their
potential as imaging probes in the monitoring of hMSC
transplantation.
MATERIALS AND METHODS
Preparation of Magnetic Nanoparticles
The bifunctional nanoparticles were synthesized using a
previously reported method (19, 20). Cobalt ferrite
magnetic nanoparticles (MNP, CoFe2O4)were coated with
a silica shell (SiO2) of stable and biocompatible material to
avoid the potential toxic effects on cells. To acquire
additional fluorescent properties, an organic fluorescent
dye (rhodamine B isothiocyanate, RITC) was incorporated
into the silica shell. Thus, the MNP@SiO2(RITC)s have a
bifunctional property which enables dual modality
detection by MRI and optical imaging. The surface of the
dual-functionalized silica-coated nanoparticles was
modified with biocompatible polyethylene glycol (PEG)
groups to render them biocompatible by preventing the
nonspecific adsorption of proteins to the nanoparticles.
Attachment of the PEG did not significantly change the
size of the nanoparticles. The average diameter of
MNP@SiO2(RITC)-PEG used in this study was about 50
nm. The characteristic properties of this compound are
summarized in Table 1. The absorption (λ max) and
emission maxima (λ em) were observed at 540 and 625 nm,
respectively.
Cell Culture
Human mesenchymal stem cells purchased from
Cambrex (Cambrex, Walkersville, MD) were used for cell
labeling. The cells were cultured in 75-cm
2 plastic culture
flasks (BD, USA) in 8 ml of medium at 37� C, in a humidi-
fied incubator at 5% CO2. The culture medium used was
mesenchymal stem cell basal medium (MSCBM, Cambrex,
Walkersville), which contains mesenchymal cell growth
supplement (MCGS, Cambrex, Walkersville), 4 mM L-
glutamine, and 100U Penicillin-Streptomycin. Next, the
hMSCs were cultured under generally established cell
conditions, transferred every three days, and split at a ratio
of 1:5 upon confluence.
Determination of Cellular MNP@SiO2(RITC)-PEG
Uptake by Confocal Laser Scanning Fluorescence
Microscopy
For the confocal imaging experiments, hMSCs were
seeded and cultured onto Lab-Tek Chambered Coverglass
(Nalge Nunc, Naperville, IL) at a density of 3 × 10
4
cells/cm
2 for 24 hours prior to labeling and staining. Next,
the cells were cultured at different concentrations of
MNP@SiO2(RITC)-PEG for 2, 4, 6 hours in a 37� C humidi-
fied incubator maintained at 5% CO2. After labeling, the
cover slips were washed twice with cell culture medium
and twice with phosphate buffer solution (PBS). The
fluorescence images were obtained using a LSM 510
confocal microscope (Zeiss, Jena, Germany) equipped with
Argon (458, 488, 514 nm) and HeNe (543, 633 nm) lasers
for fluorescence. The exposure time for fluorescence was
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Table 1. Characteristic Properties of MNP@SiO2(RITC)-PEG 
MNP@SiO2(RITC)-PEG
Cover structure Polymer carboxydextran
Core Cobalt ferrite nanoparticle 
(CoFe2O4)
Diameter of the Core 15 nm
Hydrodynamic diameter 50 nm
Fluorescence dye Rhodamine B
Absorption maxima (λ max) 540 nm
Emission maxima (λ em) 625 nmadjusted at each time point to localize the fluorochromes.
Background fluorescence was determined by analyzing
unlabeled cells. Image acquisition and analysis was
performed using the LSM 5 PASCAL software.
Determination of Intracellular Distribution by
Transmission Electron Microscopy (TEM)
MNP@SiO2(RITC)-PEG-labeled hMSCs were washed
with PBS and fixed with 2.5% glutaraldehyde (in pH 7.4
and 0.1 M PBS) for two hours. Subsequently, the
glutaraldehyde-fixed specimens were treated with 2%
osmium tetroxide buffered in 0.1 mM cacodylate buffer for
two hours. The specimens were dehydrated with graded
ethanol (50% to 100% ethanol and propylene oxide) (EM
Sciences). The samples were embedded in pure Epon resin
at 60� C for three days. Next, ultrathin sections were cut
with glass knives and a Diatome diamond knife (Reichert-
Jung, Vienna, Austria) on an ultramicrotome (RMC MTXL;
Tucson, AZ), stained with lead citrate and uranyl acetate
(both from EM Sciences), and observed by JEOL-JEM-100
CX Transmission Electron Microscopy (JEOL Ltd. Tokyo,
Japan).
In Vitro Cytotoxicity and Cell Proliferation Assay
Cell viability was assessed by a hemocytometer-based
trypan blue dye exclusion assay. To exclude the presence
of free floating cells in the growth medium, the
supernatant of the cells was controlled for floating cells
prior to trypsination. The cells were cultured in 96 well
plates. The 96 wells were incubated for two hours, four
hours, and six hours at different MNP concentrations (0,
0.5, 1, 2, 4 mg/ml). After incubation, the cells were washed
three times with PBS and dissociated using trypsin-EDTA.
Next, the cells were resuspended with 10 ml of media. A
total of 20 μ l of the cell suspension was mixed with 30 μ l of
Trypan blue solution (GIBCO, Gland Island, NY). The
fraction of dead cells was determined using a Neubauer’s
counting chamber. 
Percent viability =  
Total number of viable cells  
×100
Total cell count
Each value represents the mean ± standard error (SE) of
three independent experiments performed in triplicate.
The effects of the internalized particles on cell proliferation
were studied by comparing the growth curves of
MNP@SiO2(RITC)-PEG-labeled (4 hour incubation time
with 4 mg of MNP@SiO2[RITC]-PEG/ml growth medium)
and unlabeled hMSCs. Vision fields were counted under
the microscope at 1, 2, 3, and 4 days after labeling. Each
value represents the mean ± SE of three independent
experiments performed in triplicate.
Magnetic Resonance Imaging
Measurement of T1 and T2 Relaxivity of
MNP@SiO2(RITC)-PEG measured by a 1.5T and 3T MR
scanner: MR imaging of the test tubes was performed using
a 1.5T and 3T MR scanner (Signa, GE Medical Systems,
Milwaukee, WI) and a standard knee coil (Clinical MR
Solutions, Brookfield, WI). To avoid susceptibility artifacts
from the surrounding air in the scans, all probes were
placed in a water-containing plastic container at room
temperature (20� C). The concentrations of
MNP@SiO2(RITC)-PEG in each test tube were 0, 10, 30,
50, 100, 200, and 300 μ g/ml. To measure the T1 relaxation
times, axial spin echo sequences were obtained at multiple
TR values of 200, 300, 500, 1,000, 3,000, 5,000, 8,000,
12,000 ms with a fixed TE of 12 ms at 1.5T and 3T. To
measure the T2 relaxation times, axial T2-weighted SE
images were obtained with a TR of 4,000 ms and increas-
ing TEs of 12, 20, 50, 80, 150, 300, and 500 ms at 1.5T
and 3T. All sequences were acquired at a field of view of
130×130 mm, a matrix of 256×256 pixels, a slice
thickness of 5 mm, and one acquisition. The signal intensi-
ties of the test tubes, with contrast medium in solution at
corresponding iron concentrations, were measured using
custom written software for the region of interest analysis.
The signal intensity for each pixel, as a function of time,
was expressed as follows: SI = So(1-exp [-TR/T1]) and SI =
So exp (-TE/T2). The T1 relaxivities (r1 =ΔR1/concentra-
tion; mM
-1s
-1) and T2 relaxivities (r2 =ΔR2/concentration; 
mM
-1s
-1) at 1.5 and 3T for free solution of
MNP@SiO2(RITC)-PEG were deduced from the linear fit
of the ΔR1 and ΔR2 values displayed as a function of the
total iron concentration.
MR Phantom Studies and In Vivo MR imaging: For MR
phantom imaging, hMSCs were cultured in MSCBM
containing MNP of various concentrations (MNP concentra-
tions of 0.5, 1, 2 and 4 mg/ml). After incubation, cells were
washed three times with PBS, trypsinized, and collected in
50 ml tubes. Next, the samples were prepared by suspend-
ing 10
5 and 5×10
5 cells in 350 μ l 4% gelatin (Wako Pure
Chemical Industries, Osaka, Japan). The cell suspensions
were loaded onto 96 well plates and allowed to solidify at 4
℃. The experimental MR imaging of a phantom of labeled
hMSCs was performed with a 3T MR scanner (Signa, GE
Healthcare, Milwaukee, WI) using the three-dimensional b-
SSFP (balanced Steady-State Free Precession) pulse
sequence (FIESTA; Fast Imaging Employing Steady State
Acquisition, GE Healthcare, Milwaukee, WI) with a TR of
8.8 ms, TE of 4.1 ms, field of view of 100×100 mm, and a
voxel size of 1×1×1 mm
2. The region of interest for signal
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2. The percent
change of SI was calculated using the following equation: 
ΔSI = (SIlabeled - SIunlabeled)/ SIunlabeled×100%, where
SIlabeled and SIunlabeled were the SI of the labeled and
unlabeled cells, respectively. For animal experiments,
hMSCs were cultured in MSCBM containing 4 mg of
MNP@SiO2(RITC)-PEG/ml media for four hours. After
incubation and washing, the 0.5-1×10
6 labeled cells/200μ l
were injected into a kidney of SD (Sprague Dauley) rats
and different numbers of MNP@SiO2(RITC)-PEG-labeled
hMSCs (1×10
4, 1×10
5, 0.5×10
6, 1×10
6 mg/ml) were
injected subcutaneously into nude mice. Six hours after
injection of the labeled hMSCs, sequential MR imaging of
SD rats and nude mice were obtained with a 3T MR
scanner. Three pulse sequences were applied in the axial
and coronal plane: 3D FIESTA (TR/TE/flip angle: 8.4/
4.1/35), FSE (fast spin echo, TR/TE/flip angle:
3,500/89.8/90), and MGRE (multiple gradient-recalled
echo, TR/TE/flip angle: 800/13.4/20).
In Vivo and Ex Vivo Fluorescence Imaging
For optical imaging, nude mice were injected subcuta-
neously with the different numbers of MNP@SiO2(RITC)-
PEG-labeled hMSCs (1×10
4, 1×10
5, 0.5×10
6, 1×10
6
mg/ml) and 1×10
5 unlabeled hMSCs for the controls. We
performed in vivo fluorescence imaging using a Kodak
Image Station 4000 mm digital imaging system. And also
we excised the kidney with labeled hMSCs of SD rats after
performing MRI and subsequently performed ex vivo
fluorescence imaging to confirm the presence of the
fluorescence signal coming from the transplanted labeled
Sung et al.
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Fig. 2. Cellular distribution of MNP@SiO2(RITC)-PEG in human mesenchymal stem cells. Confocal fluorescence images of human
mesenchymal stem cells cultured with different concentrations of MNP@SiO2(RITC)-PEG (0, 0.5, 1, 2 and 4 mg/ml) for 2, 4, and 6 hours.
Fig. 1. Transverse relaxation rate (R2) versus
MNP@SiO2(RITC)-PEG concentration at 1.5T and 3T.hMSCs.
RESULTS
MNP@SiO2(RITC)-PEG showed both superparamagnetic
and fluorescent properties. The r1 and r2 relaxivity values
of the MNP@SiO2(RITC)-PEG were 0.33 and 398 mM
-1 s
-1
at 1.5T, respectively, and 0.29 and 453 mM
-1 s
-1 at 3T,
respectively (Fig. 1). The effective internalization of
MNP@SiO2(RITC)-PEG into the hMSCs was observed by
confocal laser scanning fluorescence microscopy as shown
in Figure 2. In these fluorescence images, the hMSCs
cultured with MNP@SiO2(RITC)-PEG took up a substantial
amount of MNP@SiO2(RITC)-PEG as clearly identified by
intracellular fluorescence signals, whereas those cultured
without MNP@SiO2(RITC)-PEG were not detected by
confocal LSM. There are no differences in the rate of
uptake with increasing incubation concentrations of
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Fig. 3. Transmission electron microscopy
images of human mesenchymal stem
cells embedded in MNP@SiO2(RITC)-
PEG. Human mesenchymal stem cells
were treated with 4 mg of MNP@SiO2
(RITC)-PEG/ml medium for four hours,
which was then processed for transmis-
sion electron microscopy study.
MNP@SiO2 (RITC)-PEG (arrows)
exhibited after internalization into cells.
MNP@SiO2 (RITC)-PEG-treated cell (×
10,000, 20,000). N = nucleus, M =
mitochondria
AB
Fig. 4. Cell viability. Human mesenchymal stem cells were
incubated for 2 (◇), 4, (■) and 6 hours (△) with different magnetic
nanoparticle concentrations (0, 0.5, 1, 2, 4 mg/ml) after 0 (A), 2 (B),
and 4 days (C).
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)MNP@SiO2(RITC)-PEG. Confocal LSM showed that
MNP@SiO2(RITC)-PEG particles resided in the cytoplasm
and outside of the nucleus of a cell. These results
confirmed that the MNP@SiO2(RITC)-PEG particles
exhibited a strong role in targeting hMSCs and that the
cellular uptake of MNP@SiO2(RITC)-PEG particles can be
visualized by fluorescence imaging at the cellular level. We
examined the localization and morphology of
MNP@SiO2(RITC)-PEG particles by electron microscopy.
The characteristic granular morphology of these
MNP@SiO2(RITC)-PEG particles was identified only in
MNP@SiO2(RITC)-PEG -labeled hMSCs and never in
unlabeled controls. The TEM images showed that
MNP@SiO2(RITC)-PEG were indeed internalized into the
cells and mainly resided in the cytoplasm (Fig. 3).
A trypan blue exclusion assay showed that there was no
increase in the number of floating cells in the supernatant
as determined by visual control under the microscope. In
addition, the number of adherent cell was not significantly
different between the controls and the labeled cells (Fig. 4).
After incubating for two hours with 0.5 mg
MNP@SiO2(RITC)-PEG/ml growth medium, we observed
no significant difference in the viability between controls
(unlabeled cells) and MNP@SiO2(RITC)-PEG-labeled cells.
After incubating for two hours at different concentrations
of MNP@SiO2(RITC)-PEG, the percentage of viable cells
was greater than 96%. After incubating for four hours at
different concentrations of MNP@SiO2(RITC)-PEG, cell
viability decreased by 3.5% (0.5 mg/ml), 4.9% (1 mg/ml),
7.2% (2 mg/ml), and 9.8% (4 mg/ml). After incubating for
six hours at different concentrations of MNP@SiO2(RITC)-
PEG, cell viability decreased by 5.4% (0.5 mg/ml), 6.9%
(1 mg/ml), 10.9% (2 mg/ml), and 14.4% (4 mg/ml). The
proliferation of MNP@SiO2(RITC)-PEG-labeled cells did
not significantly differ from the controls (Fig. 5). Moreover,
the mean doubling time for the labeled and unlabeled cells
was 26.8 hours.
The MR images using the FIESTA sequence from the in
vitro gelatin phantom of 5×10
5 labeled and unlabeled
MSCs of 2, 4, 6-hour culture, 1×10
5 labeled and unlabeled
MSCs of 2, 4, 6-hour culture were shown in Figure 6. The
SI changes of the labeled cells from the 4-hour culture
were -20%, -36%, -67%, and -80% at each incubation
concentration of MNP@SiO2(RITC)-PEG (0.5, 1.0, 2.0, and
4.0 mg/ml, respectively). The SI decrease for the 5×10
5
labeled cells at the 4 mg/ml incubation concentration was
71%, 80%, and 80% at 2, 4, and 6-hours of incubation,
respectively. The SI decrease of 1×105 labeled cells at the
4 mg/ml incubation concentration was 39%, 77%, and
60% at 2, 4, and 6-hours of incubation, respectively. The
overall SI change for the in vitro gelatin plate MR phantom
of the labeled hMSCs was maximal at the four hour
incubation time and 4 mg/ml incubation concentration of
Sung et al.
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Fig. 6. Experimental MRI of phantom of labeled human mesenchymal stem cells placed in 4% phantom gelatin in plastic wells. Coronal
FIESTA (GE, b-SSFP) sequence image of phantom shows marked decrease in signal intensity with increasing magnetic nanoparticle
concentration.
A. 5×10
5 cells in 4% gelatin, B. 1×10
5 cells in 4% gelatin.
1 = gelatin, 2 = unlabeled hMSCs in 4% gelatin, 3-6 = labeled hMSCs with 2-hour incubation; 7-10 = 4-hour incubation, 11-14 = 6-hour
incubation. 3, 7, 11 = labeled human mesenchymal stem cells at magnetic nanoparticle concentration of 0.5 mg/ml, 4, 8, 12, at 1 mg/ml;
5, 9, 13, at 2 mg/ml; 6, 10 ,14, at 4 mg/ml.
AB
7
Fig. 5. Proliferation index of human mesenchymal stem cells,
which were incubated for four hours with 4 mg/ml
MNP@SiO2(RITC)-PEG is shown (■). Control (◇).MNP@SiO2(RITC)-PEG. The labeled hMSCs containing
tubes revealed a color fluorescent signal in the tubes. In
order to examine the ability of MRI to detect transplanted
stem cells, we injected labeled hMSCs into the kidneys of
SD rats. The animals were imaged in vivo at six hours after
implantation of the labeled cells with several pulse
sequences. The imaging revealed a significant drop in
signal intensity at the area of cell implantation (Fig. 7).
However, the fluorescence signal cannot be detected in the
rats in vivo. The fluorescent signal coming from the
transplanted labeled hMSCs was detected at the excised
kidney. The fluorescence signal of the MNP@SiO2(RITC)-
PEG-labeled hMSCs could be imaged in vivo with a
subcutaneous injection of a variable number of the labeled
hMSCs into nude mice (Fig. 8). The subcutaneously
inoculated labeled hMSCs showed a fluorescent signal in
nude mice. However, no fluorescent signal was observed
when the labeled cells were deeply seated in the body of
the mice. The depth of the subcutaneous injection and
imaged sites or positions significantly influenced the
detectability of the fluorescent signal coming from the
injected labeled MSCs.
DISCUSSION
Superparamagnetic iron oxide nanoparticles and their
composites are the most popular contrast agents for
tracking and studying stem cells by MRI. Unfortunately,
the internalizing efficiency of the iron oxide nanoparticles
is generally low. The labeling of the cultured stem cells
with superparamagnetic iron oxide nanoparticles requires
long-term incubation; from approximately 10 hours to a
few days in previous studies, despite the various coating
material substitutes (14, 15, 21). Popular MRI contrast
agents, such as Feridex (AMAG Pharmaceuticals Inc.,
Cambridge, MA), require the addition of a transfecting
agent (internalization agent) for efficient cellular uptake
(22). In this study, we demonstrated that the synthesized
MNP@SiO2(RITC)-PEG could be efficiently internalized
into hMSCs without the assistance of the transfecting
agent. In addition, the incubation time used to label the
hMSCs was short and the nanoparticles were substantially
Nanoprobes for Depicting Mesenchymal Stem Cell Transplant by MRI and Fluorescence Imaging
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AB
Fig. 7. Sequential in vivo MR imaging (3T, 3.0 mm slices) and fluorescence imaging of SD rat after injection with MNP@SiO2(RITC)-
PEG-labeled human mesenchymal stem cells. 
A-D. MR images with fast spin echo (TR/TE: 3,500/89.8) (A), 3D fast imaging employing steady state acquisition (TR/TE/flip angle: 8.4/
4.1/35) (B), multiple gradient-recalled echo (TR/TE/flip angle: 800/13.4/20) (C), and fluorescent signal coming from labeled human
mesenchymal stem cells in kidney of SD rat (arrows) can only be detected in excised state (D).
CDinternalized during the first two hours of incubation. The
maximal signal drop in MRI was seen at the four hour
incubation time amongst the comparison of the 2, 4 and 6
hours incubation times. The improved labeling efficiency
with the short incubation time and the independent
transfecting agent might be contributed by the surface
modification with PEG groups. PEG coatings of silica shells
provides biocompatibility by preventing nanoparticle
agglomeration and nonspecific adsorption of proteins to
the nanoparticles, thus increasing the particle blood circula-
tion time and the efficiency of their internalization by
targeted cells when introduced in vivo (23). A recent study
revealed that amorphous silica may present toxicity
concerns at high doses (24). The cytotoxic effects of silica
nanoparticles can be significantly reduced by surface
modification of silica shells with chitosan or PEG (20, 24).
The surface properties of nanoparticles influence its
uptake mechanisms. Further, there are different
mechanisms for the cellular internalization of the magnetic
nanoparticles. However, the best known is the clathrin-
dependent endocytosis (25, 26). Kim et al. (26) showed
that the uptake of magnetic nanoparticles into the cells is
an energy-dependent process and it is mediated through
endosomes. After entering the cytoplasm, the ingested
nanoparticles are delivered to early endosomes and then
transported to the lysosome. The ingested nanoparticles
can be stored in different compartments (such as mitochon-
dria) in the cytoplasm (25). The TEM images in this study
showed the intracytoplasmic localization of the internal-
ized nanoparticles with a granular appearance. The
effective energy-dependent endocytic uptake of the
nanoparticles may allow the simultaneous intracellular
uptake of the drugs- or genes-of-interest by the formation
of complex molecules when the surface of the nanoparti-
cles is optimally modified (26).
We demonstrated that MNP@SiO2(RITC)-PEG was less
toxic without affecting the cell viability and cell prolifera-
tion of hMSCs after MNP@SiO2(RITC)-PEG-treated cells
were incubated with growth medium for various lengths of
time. These facts indicated that MNP@SiO2(RITC)-PEGs
are quite biocompatible. The noncovalent surface modifi-
cation of the nanoparticles has a serious limitation for
biological applications, because the exposed metal ion on
the surface of nanoparticles can cause metal elemental
toxicities in cells (in vivo model) (27). In our research,
silica (SiO2) was selected for the surface modification of
MNPs because it is a good biocompatible material and
resistant to decomposition in vivo (20). Consequently,
silica-coated core-shell nanoparticles have been
extensively studied over the past decade (25), and were
recently synthesized with a functionalized surface for
bioconjugation through various simple methods that are
Sung et al.
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Fig. 8. In vivo MR imaging (A) and fluorescence imaging (B) of nude mouse after subcutaneous injection of labeled and unlabeled
human mesenchymal stem cells with MNP@SiO2(RITC)-PEG (1 = 1×10
5 unlabeled human mesenchymal stem cells for control, 2 = 1×
10
6 labeled human mesenchymal stem cells, 3 = 1×10
5 labeled human mesenchymal stem cells). Labeled human mesenchymal stem
cells are clearly seen as dark dot (arrow) in subcutaneous layer of nude mouse on axial scan of fast spin echo sequence. Fluorescent
signal of subcutaneously injected human mesenchymal stem cells is detected at injection sites of labeled cells. Injection sites of
unlabeled cells shows autofluorescence-induced artifact. 
AB
1
2
3applicable in biological systems. To improve the versatility
of silica-coated core-shell nanomaterials, an organic
fluorescent dye was incorporated into the silica shell. Thus,
the magnetic and fluorescence properties enable the dual
detection of the silica-coated core-shell magnetic nanopar-
ticles (MNP@SiO2). The additional advantage provided by
the incorporation of a fluorescent dye into the silica shell is
the significant increase in photochemical stability, resulting
in minimal photobleaching even after multiple exposures.
This aforementioned topic is of great importance among
researchers using confocal laser scanning microscopy (20).
Several imaging modalities are currently in use for the
molecular and cellular imaging techniques. Unlike the
previous approaches in stem cell research that required the
processing of fixed tissue samples, these imaging modalities
enable the imaging of living, intact transplanted cells in
vivo. Since each imaging modality has its own merits and
disadvantages, multi-modality imaging has emerged as a
strategy that combines the strengths of different imaging
methods. Multi-modality imaging can be achieved by the
development of true hybrid systems that collect images
under the same condition and by the development of
sophisticated technologies for image registration and
fusion. The development of multifunctional contrast agents
can be another way to develop multimodal imaging.
Recently, the synthesis of similar nanoparticles for dual
modal imaging was reported by various authors (18, 23,
28, 29). They reported that the bifunctional nanoparticles
can be used for magnetic resonance as well as the optical
imaging of human stem cells, brain tumor, and sentinel
lymph node. Despite the rapid advances in optical imaging,
there are several challenges in the development of highly
sensitive and photostable nanoparticles with a substantial
penetration depth. We used organic dyes (RITC) to
provide the magnetic nanoparticles with their fluorescent
property. The use of organic dyes for stem cell imaging
might be limited, since these dyes are often cleared rapidly
and thus require a large quantity of dye for optical
imaging. For this reason, the light in the near-infrared
region of 650 nm-900 nm is most commonly used in
practical applications (30). It is still necessary to develop
suitable optical probes for deep tissue optical imaging.
The quality of a contrast agent for MRI is dependent on
its relaxivity. In this study, the synthesized nanoparticles in
an aqueous solution showed significantly higher r2 relaxiv-
ity (398 mM
-1 s
-1 at 1.5T and 453 mM
-1 s
-1 at 3T) and a
higher r2/r1 relaxivity ratio compared to commercially
available superparamagnetic iron oxide nanoparticles
(ferumoxide and ferucarbotran). Thus, the T2 effect
dominates and the MNP@SiO2(RITC)-PEG can be a good
T2/T2* agent. The contrast agents exhibit magnetic and
optical properties. This bifunctional property enables the
simultaneous detection by MRI and optical imaging. We
found that MRI and fluorescence imaging can facilitate the
identification of labeled stem cells, both in vitro and in
vivo and thus, provide an accurate estimate of cell
delivery. However, fluorescence imaging showed limita-
tions in penetration depth and consequently visualized the
subcutaneously injected labeled hMSCs. However, the
deep seated stem cells in small animal cannot be visual-
ized. Although the biomedical application of optical
imaging is still limited, the combination of MRI and optical
imaging can extend their utilities for molecular and cellular
imaging.
In the past decade, the therapeutic use of mesenchymal
stem cells in tissue regeneration has been under intense
investigation. To date, the true functional role of MSCs in
vivo is not clear (31). MSCs may act by paracrine or even
endocrine mechanisms related to the production of a broad
array of mediators and growth factors with immunosup-
pressive, anti-inflammatory, antiapoptotic and proliferative
effects (32). There is a general consensus that the field of
MSC biology is significantly less developed than other
stem cell fields. Therefore tracking the distribution and
migration of the transplanted MSCs in the patients are
important for the development of their therapeutic use.
One innovative development for stem cell tracking is the
multimodal imaging which might be a powerful method for
in vivo visualization of transplanted stem cells by using the
combined strengths of each modality. In this study, we
demonstrated a bifunctional (magneto/optical) contrast
agent using a synergistic integration of magnetic nanoparti-
cles with fluorescent molecules to serve as a good imaging
probe for stem cell research. Owing to its bifunctional
property, dual modality detection was simultaneously
achieved using a single material. The dual modal imaging
using magneto/optical nanoparticles is expected to give
good anatomical information via MRI, along with more
detailed subcellular information via fluorescence imaging
taken at the same point. 
In this study, we have demonstrated that
MNP@SiO2(RITC)-PEG could be efficiently internalized
into hMSCs and was less toxic (no significant effect on cell
viability and proliferation). As well, the hMSCs labeled
with MNP@SiO2(RITC)-PEG were detected in vitro and in
vivo, and noninvasively traced by both optical imaging and
MRI. In conclusion, although further investigations are
needed for stem cell tracking, this study suggests
MNP@SiO2(RITC)-PEG is a useful contrast agent for stem
cell imaging, which is suitable for a bimodal detection by
MRI and optical imaging.
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